Nurses are crucial to the health and wellbeing of our communities, and play a pivotal role in patient education and chronic disease management.1
AstraZeneca is pleased to provide Patient Care Planning resources to support your patients diagnosed with Chronic Kidney Disease. These resources have been designed for nurses by nurses, and tested with the input of patients and health literacy experts.
Patient Care Planning Resources
Checking Kidney Health
What Do Your Kidneys Do
Kidney Sick Day Template
Blood Pressure & CKD
Additional Resources
Forxiga® Patient Information
Forxiga® Patient Information – First Nations Peoples
Resources for Healthcare Professionals
Diagnose CKD Website
CARI First Nations
CKD Management Guidelines
FORXIGA® use in Proteinuric Chronic
Kidney Disease: website
Request more information from an AstraZeneca representative
PLEASE CLICK HERE TO REVIEW FULL PRODUCT INFORMATION BEFORE PRESCRIBING.
FURTHER INFORMATION AVAILABLE ON REQUEST FROM ASTRAZENECA.
PBS Information: FORXIGA: Type 2 Diabetes, Chronic Heart Failure and Chronic Kidney Disease. |
References:
1. Australia Primary Health Care Nurses Association. (APNA). Nursing in Primary Health Care Program. Available at: https://www.apna.asn.au/profession/niphc. Accessed May 2023.
FORXIGA® is a registered trademark of the AstraZeneca group of companies. Registered user AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road, Macquarie Park, NSW 2113. www.astrazeneca.com.au. For Medical Information enquiries or to report an adverse event or product quality complaint: Telephone 1800 805 342 or via https://contactazmedical.astrazeneca.com Or email Medical Information enquiries to medinfo.australia@astrazeneca.com. AU-15551. July 2023.